HK1086487A1 - Alpha-aminoamide derivatives useful as antimigraine agents - Google Patents

Alpha-aminoamide derivatives useful as antimigraine agents

Info

Publication number
HK1086487A1
HK1086487A1 HK06106511.1A HK06106511A HK1086487A1 HK 1086487 A1 HK1086487 A1 HK 1086487A1 HK 06106511 A HK06106511 A HK 06106511A HK 1086487 A1 HK1086487 A1 HK 1086487A1
Authority
HK
Hong Kong
Prior art keywords
alpha
antimigraine agents
derivatives useful
aminoamide derivatives
aminoamide
Prior art date
Application number
HK06106511.1A
Other languages
English (en)
Inventor
Patricia Salvati
Marcello Calabresi
Dho L Luciano
Orietta Veneroni
Piero Melloni
Original Assignee
Newron Pharm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newron Pharm Spa filed Critical Newron Pharm Spa
Publication of HK1086487A1 publication Critical patent/HK1086487A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
HK06106511.1A 2003-01-16 2006-06-07 Alpha-aminoamide derivatives useful as antimigraine agents HK1086487A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03000921A EP1438956A1 (en) 2003-01-16 2003-01-16 Alpha-aminoamide derivatives useful as antimigraine agents
PCT/EP2003/012889 WO2004062655A1 (en) 2003-01-16 2003-11-18 Alpha-aminoamide derivatives useful as antimigraine agents

Publications (1)

Publication Number Publication Date
HK1086487A1 true HK1086487A1 (en) 2006-09-22

Family

ID=32524140

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06106511.1A HK1086487A1 (en) 2003-01-16 2006-06-07 Alpha-aminoamide derivatives useful as antimigraine agents

Country Status (21)

Country Link
US (2) US7709523B2 (ko)
EP (2) EP1438956A1 (ko)
JP (1) JP4885455B2 (ko)
KR (1) KR101049694B1 (ko)
CN (1) CN100418517C (ko)
AT (1) ATE380026T1 (ko)
AU (1) AU2003279399B8 (ko)
BR (1) BRPI0317795B8 (ko)
CA (1) CA2510514C (ko)
CY (1) CY1107274T1 (ko)
DE (1) DE60317935T2 (ko)
DK (1) DK1585510T3 (ko)
ES (1) ES2295658T3 (ko)
HK (1) HK1086487A1 (ko)
MX (1) MXPA05007339A (ko)
NO (1) NO333610B1 (ko)
NZ (1) NZ541117A (ko)
PT (1) PT1585510E (ko)
RU (1) RU2336077C2 (ko)
SI (1) SI1585510T1 (ko)
WO (1) WO2004062655A1 (ko)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9727523D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
NZ531586A (en) * 2001-09-03 2005-09-30 Newron Pharm Spa Pharmaceutical composition comprising gabapentin or an analogue thereof and an alpha-aminoamide and its analgesic use
KR101233711B1 (ko) * 2003-08-25 2013-02-18 뉴론 파마슈티칼즈 에스. 피. 에이. 항염증제로서 유용한 알파-아미노아미드 유도체
PT1809271E (pt) * 2004-09-10 2010-08-30 Newron Pharm Spa Utilização de (halogenobenziloxi)benzilamino-propanamidas para o fabrico de medicamentos activos como moduladores selectivos dos canais de sódio e/ou de cálcio
RS54522B1 (en) 2005-12-22 2016-06-30 Newron Pharmaceuticals S.P.A. 2-Phenylethylamino Derivatives as Modulators of Calcium and (or Sodium) Channels
DK2474521T3 (en) 2006-06-19 2016-10-31 Newron Pharm Spa High-purity 2- [4- (3- and 2-fluorobenzyloxy) benzylamino] propanamides for use as pharmaceuticals and pharmaceutical formulations thus
FR2903985B1 (fr) 2006-07-24 2008-09-05 Sanofi Aventis Sa Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
ES2655704T3 (es) 2007-06-15 2018-02-21 Newron Pharmaceuticals S.P.A. Derivados de 2-[2-(fenil)etilamino]alcanoamida sustituidos y su uso como moduladores de canales de calcio y/o sodio
SI2229351T1 (en) 2007-12-11 2018-02-28 Newron Pharmaceuticals S.P.A. PROCEDURE FOR PREPARATION OF 2- (4- (3-OR 2-FLUOROBENYLOXYL) BENZYLAMINO) PROPANAMIDES WITH A HIGH PURITY Purity
EP2314569A1 (en) 2009-10-22 2011-04-27 Merck Patent GmbH Novel polymorphic forms of (S)-2-[4-(3-Fluoro-benzyloxy)-benzylamino]-propionamide mesylate salt and processes of manufacturing thereof
NZ602648A (en) 2010-04-27 2014-10-31 Newron Pharm Spa Process for the production of ralfinamide methanesulfonate salts or their r-enantiomers
KR101705718B1 (ko) * 2013-12-30 2017-02-14 이화여자대학교 산학협력단 신규한 아미드 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 포함하는 통증의 예방 또는 치료용 약학적 조성물
CN107522654B (zh) * 2016-06-21 2020-09-01 中国人民解放军军事医学科学院毒物药物研究所 新的α-氨基酰胺衍生物及其医药用途
WO2019205147A1 (zh) * 2018-04-28 2019-10-31 上海璃道医药科技有限公司 包含苯并含氧脂肪环结构的氨基乙酰胺类化合物及其用途
CN112716927B (zh) * 2020-10-12 2022-10-14 复旦大学 α-氨基酰胺类化合物及其制备方法与应用

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1140748A (en) 1966-06-23 1969-01-22 Ici Ltd New carboxylic acid derivatives
US3658967A (en) 1966-06-23 1972-04-25 Ici Ltd Carboxylic acid derivatives for lowering the concentration of triglycerides in the blood
CH480308A (de) 1966-08-11 1969-10-31 Ciba Geigy Verfahren zur Herstellung von Thiosemicarbazid-Verbindungen
US4049663A (en) 1972-06-06 1977-09-20 Allen & Hanburys Limited Ethylene diamine derivatives
US4311853A (en) 1979-02-06 1982-01-19 The Radiochemical Centre Limited Selenium derivatives of thyroxine and tri-iodothyronine
DE3010599A1 (de) 1979-03-22 1980-10-09 Continental Pharma Derivate von glycinamid, deren herstellung und verwendung
US4267354A (en) 1979-04-25 1981-05-12 E. R. Squibb & Sons, Inc. Substituted amides having antiinflammatory activity and intermediates
ZA805476B (en) 1979-09-26 1981-11-25 Robins Co Inc A H 2-amino-3-benzoyl-phenylacetamides and cyclic homologues
FR2480747A1 (fr) 1980-04-17 1981-10-23 Roques Bernard Derives d'acides amines et leur application therapeutique
DE3483308D1 (de) 1983-11-21 1990-10-31 Fujisawa Pharmaceutical Co Semicarbazid-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
US4839369A (en) 1985-04-16 1989-06-13 Rorer Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4725619A (en) 1985-04-16 1988-02-16 Usv Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4631287A (en) 1985-04-16 1986-12-23 Usv Pharmaceutical Corp. Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
GB8714901D0 (en) 1986-07-23 1987-07-29 Ici Plc Amide derivatives
GB2216515A (en) 1988-03-04 1989-10-11 Nippon Shinyaku Co Ltd Acylphenol derivatives
IL94466A (en) 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
DE3928488A1 (de) 1989-08-29 1991-03-07 Standard Elektrik Lorenz Ag Interferometrisches messsystem
EP0525360B1 (en) 1991-07-30 1998-03-25 Korea Research Institute Of Chemical Technology Novel phenylacetamide derivatives and processes for the preparation thereof
US5498610A (en) 1992-11-06 1996-03-12 Pfizer Inc. Neuroprotective indolone and related derivatives
GB9306886D0 (en) 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation
GB9306899D0 (en) 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
US5475007A (en) 1993-05-28 1995-12-12 The Regents Of The University Of California 1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes and the use thereof
US5482964A (en) 1994-10-11 1996-01-09 Warner-Lambert Company Substituted phenoxyhydroxypropyl amines as central nervous system agents
US5541204A (en) 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
KR0147963B1 (ko) 1995-01-10 1998-08-17 강박광 엔-아릴알킬페닐아세트아미드 유도체와 그의 제조방법
US5849737A (en) 1995-04-14 1998-12-15 The Regents Of The University Of California Compositions and methods for treating pain
US5741818A (en) 1995-06-07 1998-04-21 University Of Saskatchewan Semicarbazones having CNS activity and pharmaceutical preparations containing same
GB9515412D0 (en) 1995-07-27 1995-09-27 Pharmacia Spa 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
GB9515411D0 (en) 1995-07-27 1995-09-27 Pharmacia Spa N-(4-substituted-benzyl)-2-aminolactam derivatives
US5688830A (en) 1996-01-25 1997-11-18 Syntex (U.S.A.) Inc. Treatment of neuropathic pain
JP4160136B2 (ja) * 1996-08-29 2008-10-01 武田薬品工業株式会社 縮合環状エーテル類、その製造法および剤
TW492957B (en) 1996-11-07 2002-07-01 Novartis Ag N-substituted 2-cyanopyrrolidnes
GB9625795D0 (en) 1996-12-12 1997-01-29 Smithkline Beecham Plc Novel treatment
GB9706730D0 (en) 1997-04-03 1997-05-21 Pharmacia & Upjohn Spa 2-[(3-substituted)-5-Isoxazolymethylaminojalkanamid derivatives
ATE289295T1 (de) 1997-04-22 2005-03-15 Euro Celtique Sa Die verwendung von durch carbozyklische und heterozyklische reste substituierte semicarbazonen und thiosemicarbazonen als natriumkanalblocker
CA2310664C (en) 1997-11-21 2008-03-11 Euro-Celtique S.A. Substituted 2-aminoacetamides and the use thereof
GB9727523D0 (en) * 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
GB9727521D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Substituted 2-benzylamino-2-phenyl-acetamide compounds
WO1999039712A1 (en) 1998-02-04 1999-08-12 Euro-Celtique S.A. Substituted semicarbazides and the use thereof
JP2000191533A (ja) * 1998-10-19 2000-07-11 Eisai Co Ltd 鎮痛剤
KR20010103583A (ko) * 1998-10-19 2001-11-23 다니구치 미즈오 진통제
US6281211B1 (en) 1999-02-04 2001-08-28 Euro-Celtique S.A. Substituted semicarbazides and the use thereof
TR200102790T2 (tr) * 1999-03-26 2002-06-21 Euro-Celtique S.A. Aril İkameli Pirazoller, İmidazoller, Oksazoller, Tiazoller ve Piroller Ve Bunların Kullanımı.
JP2002541215A (ja) * 1999-04-09 2002-12-03 ユーロ−セルティック エス． ア． ナトリウムチャネル遮断薬組成物およびその使用
NZ531586A (en) * 2001-09-03 2005-09-30 Newron Pharm Spa Pharmaceutical composition comprising gabapentin or an analogue thereof and an alpha-aminoamide and its analgesic use
AR044007A1 (es) 2003-04-11 2005-08-24 Newron Pharmaceuticals Inc Metodos para el tratamiento de la enfermedad de parkinson
EP1588704A1 (en) 2004-04-22 2005-10-26 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders
PT1809271E (pt) 2004-09-10 2010-08-30 Newron Pharm Spa Utilização de (halogenobenziloxi)benzilamino-propanamidas para o fabrico de medicamentos activos como moduladores selectivos dos canais de sódio e/ou de cálcio

Also Published As

Publication number Publication date
DE60317935D1 (de) 2008-01-17
PT1585510E (pt) 2008-02-28
WO2004062655A1 (en) 2004-07-29
US20060079570A1 (en) 2006-04-13
JP2006514060A (ja) 2006-04-27
US20100267835A1 (en) 2010-10-21
CY1107274T1 (el) 2012-11-21
KR101049694B1 (ko) 2011-07-19
AU2003279399B8 (en) 2009-01-29
NO333610B1 (no) 2013-07-22
BR0317795A (pt) 2005-11-22
DE60317935T2 (de) 2008-11-27
CA2510514C (en) 2011-07-26
JP4885455B2 (ja) 2012-02-29
ES2295658T3 (es) 2008-04-16
CA2510514A1 (en) 2004-07-29
RU2005125919A (ru) 2006-01-10
EP1585510B1 (en) 2007-12-05
US7709523B2 (en) 2010-05-04
CN100418517C (zh) 2008-09-17
RU2336077C2 (ru) 2008-10-20
DK1585510T3 (da) 2008-02-25
CN1738611A (zh) 2006-02-22
KR20050094852A (ko) 2005-09-28
BRPI0317795B8 (pt) 2021-05-25
EP1438956A1 (en) 2004-07-21
NZ541117A (en) 2008-02-29
AU2003279399A1 (en) 2004-08-10
MXPA05007339A (es) 2005-09-30
AU2003279399B2 (en) 2008-11-27
NO20053780L (no) 2005-10-13
EP1585510A1 (en) 2005-10-19
SI1585510T1 (sl) 2008-04-30
NO20053780D0 (no) 2005-08-09
BRPI0317795B1 (pt) 2019-04-02
ATE380026T1 (de) 2007-12-15

Similar Documents

Publication Publication Date Title
HK1086487A1 (en) Alpha-aminoamide derivatives useful as antimigraine agents
TW200510301A (en) Novel compounds
TW200510303A (en) Novel compounds
TW200407305A (en) Novel compounds
SE0203713D0 (sv) Novel compounds
MY147478A (en) Microbiologically stabilised beer
TW200626068A (en) Active compounds for seed treatment
TW200510334A (en) Preraration and use of aryl alkyl acid derivatives for the treatment of obesity
TNSN05045A1 (en) Indole or benzimidazole derivatives for modulating ikappab kinase
HK1119699A1 (en) Pyridopyrimidinone inhibitors of pi3kalpha
WO2007062999A3 (en) 1,5-substituted indol-2-yl amide derivatives
TW200510407A (en) Novel pyrrolodihydroisoquinolines as PDE 10 inhibitors
GB0510143D0 (en) Novel compounds A1
TW200736229A (en) Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors
IL189298A0 (en) 3.5-disubstituted phenyl-piperidines as modulators of dopamine meurotransmission
MX2008013196A (es) 5-amido-2-carboxiamida-indoles.
PL1900362T3 (pl) Pochodne alfa-aminoamidu użyteczne w leczeniu zaburzeń uzależnieniowych
NO20082096L (no) Azaindol-2-karboksamidderivativer
WO2007047447A3 (en) Diuretic-like compound analogs useful for regulation of central nervous system disorders
IL191751A0 (en) Pyrrolo[2,3-c]pyridine derivatives
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
TW200738143A (en) Use of arylanilides for seed treatment
MXPA05013151A (es) 3-fluoro-piperidinas como antagonistas de n-metil-d-aspartato/nr2b.
EP1441724B8 (en) Methods of increasing endogenous testosterone levels
TW200505435A (en) Treatment of ocular disorders

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20231117